Participation of women in cardiovascular trials from 2017 to 2023: a systematic review

31 August 2025 (10:55 - 11:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Martha Gulati

Houston Methodist DeBakey Heart & Vascular Center, Houston (United States of America)

4 More presentations in this session

Presentation thumbnail

Postmenopausal hormone therapy and major adverse cardiac events in women with prior myocardial infarction

Doctor H. Wood-Kurland (Hilleroed, DK)

Abstract Slides Video

Presentation thumbnail

Gender differences in the performance of the Chest Pain score and modified HEART score in risk stratification for cardiac events in patients presenting to the Emergency Department with chest pain

Doctor L. Pelagatti (Florence, IT)

Abstract Slides Video

Presentation thumbnail

Cardiovascular risk in autoimmune diseases: associations and interactions with traditional risk factors in a prospective population-based cohort of 450 000 individuals

Mr A. Schuermans (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Distinct risk patterns of mid-trimester systolic-diastolic blood pressure for individual and co-occurring adverse pregnancy outcomes

Miss F. Yiwen (Tianjin, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular health in women: from hormones to high-risk conditions

The Event

Event poster

ESC Congress 2025

31 August 2025 10:55 CET

You may be interested in

Congress Presentation

Women in cardiovascular trials - what are we doing wrong?

Congress Session

Advancing women's cardiovascular health: global strategies and innovations

Congress Presentation

Bias in cardiovascular care: why is cardiovascular disease often missed in women?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources